Measure would save money for Utah patients and taxpayers.
We appreciate President Trump’s continued focus on the country’s drug pricing crisis. But, two years into his term, prices are still going up, patients are still struggling, and Big Pharma is breaking records lobbying Congress to keep it that way.
We look forward to helping Congress stand up to the drug industry and begin to actually lower drug prices for patients.
Patients For Affordable Drugs Now Takes Major Action in Support of International Pricing Index and Medicare Part B Reforms.
More than 1,500 patient advocates agree: the Department of Health and Human Services’ proposal to lower drug prices in Medicare Part B must move forward.
Voters DO NOT buy Big Pharma’s spin that the IPI will harm patient access to drugs
Under the draft proposal from the Department of Health and Human Services, prices for expensive infused drugs administered in physician offices and hospitals would be brought more in line with what people in other wealthy nations pay.
The plan will allow us to negotiate better on the price of drugs and will effectively bring our costs down by over 50 percent. That would make a difference for my peace of mind and the health of many Americans like me.